Recall Ledger

Amlodipine and Olmesartan Medoxomil Tablets recall (Ascend Laboratories, LLC)

DrugClass IIOngoing

Summary: Ascend Laboratories, LLC is recalling Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30. Reason: Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications.

What is being recalled

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30

Why

Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

Nationwide in the USA

How to tell if yours is affected

Lot 25121311, expiry 3/31/2028

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0712-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedJuly 8, 2026
ReportedJuly 29, 2026
CompanyAscend Laboratories, LLC
Company locationBedminster, NJ, United States
Initiated byVoluntary: Firm initiated
Quantity6,192 bottles

More recalls from Ascend Laboratories, LLC · all drug recalls · recalls from July 2026

Official FDA record